Workshop 16
Molecular Infection Epidemiology and Prediction of Antimicrobial Resistance 2 (FG MS)

Programme

• 14:00 – 14:15 10 Min. 5 Min.

  • Vortrag
  • MSV 086

  Distribution of ESBL-carrying plasmids in Escherichia coli and Klebsiella pneumoniae recovered from long-term care facility residents, staff, and linked aquatic environments: a European multi-center study

  • Julia Guther (Tübingen, DE)

   Molecular Infection Epidemiology and Prediction of Antimicrobial Resistance (FG MS)
• 14:15 – 14:30 10 Min. 5 Min.

  • Vortrag
  • MSV 087

  Unveiling the diversity and characteristics of plasmids in non-tuberculous mycobacteria: insights from a comprehensive genomic study

  • Margo Diricks (Borstel, DE)

   Molecular Infection Epidemiology and Prediction of Antimicrobial Resistance (FG MS)
• 14:30 – 14:45 10 Min. 5 Min.

  • Vortrag
  • MSV 088

  The mysterious spread of OXA-244 producing E.coli ST38, insights of an genomic-epidemiological investigation in Germany, 2013-2021

  • Felix Reichert (Berlin, DE)

   Molecular Infection Epidemiology and Prediction of Antimicrobial Resistance (FG MS)
• 14:45 – 15:00 10 Min. 5 Min.

  • Vortrag
  • MSV 089

  Beyond sequential blockade: how the trimethoprim-sulfamethoxazole combination induces pleotropic cellular responses in susceptible bacteria

  • Natasha Delgado (Sydney, AU)

   IPC and MDRO and nosocomial pathogens (FG PR HY/StAG Hyg)
• 15:00 – 15:15 10 Min. 5 Min.

  • Vortrag
  • MSV 090

  Pre-clinical assessment of the chlorotonil derivative WH0182 as potent novel antibacterial agent active against multidrug-resistant Gram-positive bacteria

  • Felix Deschner (Saarbrücken, DE)
  • Markus Bischoff (Homburg, DE)

   IPC and MDRO and nosocomial pathogens (FG PR HY/StAG Hyg)
• 15:15 – 15:30 10 Min. 5 Min.

  • Vortrag
  • MSV 091

  Development of resistance to Ceftazidime/Avibactam in bla_OXA244-carrying Escherichia coli during therapy, associated with mutations in acrB and mrdA

  • Kaan Koçer (Heidelberg, DE)

   Molecular Infection Epidemiology and Prediction of Antimicrobial Resistance (FG MS)